The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets?

Bibliography

• Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121(12):953-9
   PubMed Web of Science ®Google Scholar
• Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet 2006;367(9507):346-55
   PubMed Web of Science ®Google Scholar
• Buchwald D. Fibromyalgia and chronic fatigue syndrome: similarities and differences. Rheum Dis Clin North Am 1996;22(2):219-43
   PubMed Web of Science ®Google Scholar
• Goldenberg DL, Simms RW, Geiger A, Komaroff AL. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum 1990;33(3):381-7
   PubMed Web of Science ®Google Scholar
• Meeus M, Nijs J, Meirleir KD. Chronic musculoskeletal pain in patients with the chronic fatigue syndrome: a systematic review. Eur J pain (London, England) 2007;11(4):377-86
   PubMedGoogle Scholar
• Nijs J, Vaes P, McGregor N, et al. Psychometric properties of the Dutch Chronic Fatigue Syndrome–Activities and Participation Questionnaire (CFS-APQ). Phys Ther 2003;83(5):444-54
   PubMedGoogle Scholar
• Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33(2):160-72
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62(5):600-10
   PubMed Web of Science ®Google Scholar
• Nijs J, Meeus M, Van Oosterwijck J, et al. In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur J Clin Invest 2012;42(2):203-12
   PubMed Web of Science ®Google Scholar
• Theorell T, Blomkvist V, Lindh G, Evengard B. Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. Psychosom Med 1999;61(3):304-10
   PubMed Web of Science ®Google Scholar
• Van Houdenhove B, Neerinckx E, Onghena P, et al. Premorbid "overactive" lifestyle in chronic fatigue syndrome and fibromyalgia. An etiological factor or proof of good citizenship? J Psychosom Res 2001;51(4):571-6
   PubMed Web of Science ®Google Scholar
• Chung CP, Titova D, Oeser A, et al. Oxidative stress in fibromyalgia and its relationship to symptoms. Clin Rheumatol 2009;28(4):435-8
   PubMedGoogle Scholar
• Miyamae T, Seki M, Naga T, et al. Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation. Redox Rep 2013;18(1):12-19
   PubMed Web of Science ®Google Scholar
• Neyal M, Yimenicioglu F, Aydeniz A, et al. Plasma nitrite levels, total antioxidant status, total oxidant status, and oxidative stress index in patients with tension-type headache and fibromyalgia. Clin Neurol Neurosurg 2013;115(6):736-40
   PubMed Web of Science ®Google Scholar
• Cordero MD, de Miguel M, Carmona-Lopez I, et al. Oxidative stress and mitochondrial dysfunction in fibromyalgia. Neuro Endocrinol Lett 2010;31(2):169-73
   PubMed Web of Science ®Google Scholar
• Cordero MD, Cano-Garcia FJ, Alcocer-Gomez E, et al. Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q(1)(0) effect on clinical improvement. PLoS One 2012;7(4):e35677
   PubMed Web of Science ®Google Scholar
• Kennedy G, Spence VA, McLaren M, et al. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radical Biol Med 2005;39(5):584-9
   PubMed Web of Science ®Google Scholar
• Cordero MD, De Miguel M, Moreno Fernandez AM, et al. Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease. Arthritis Res Ther 2010;12(1):R17
   PubMed Web of Science ®Google Scholar
• Ozgocmen S, Ozyurt H, Sogut S, et al. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int 2006;26(7):598-603
   PubMedGoogle Scholar
• Maes M, Twisk FN. Chronic fatigue syndrome: harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Med 2010;8:35
   PubMed Web of Science ®Google Scholar
• Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271(5 Pt 1):C1424-37
   PubMed Web of Science ®Google Scholar
• Radi R, Rodriguez M, Castro L, Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994;308(1):89-95
   PubMedGoogle Scholar
• Pall ML. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med Hypotheses 2000;54(1):115-25
   PubMedGoogle Scholar
• Nardin RA, Johns DR. Mitochondrial dysfunction and neuromuscular disease. Muscle Nerve 2001;24(2):170-91
   PubMed Web of Science ®Google Scholar
• Vermeulen RC, Kurk RM, Visser FC, et al. Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity. J Transl Med 2010;8:93
   PubMed Web of Science ®Google Scholar
• Booth NE, Myhill S, McLaren-Howard J. Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Int J Clin Exp Med 2012;5(3):208-20
   PubMed Web of Science ®Google Scholar
• Myhill S, Booth NE, McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med 2009;2(1):1-16
   PubMed Web of Science ®Google Scholar
• Smits B, van den Heuvel L, Knoop H, et al. Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome. Mitochondrion 2011;11(5):735-8
   PubMed Web of Science ®Google Scholar
• Behan WM, More IA, Behan PO. Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol 1991;83(1):61-5
   PubMedGoogle Scholar
• Vecchiet L, Montanari G, Pizzigallo E, et al. Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome. Neurosci Lett 1996;208(2):117-20
   PubMedGoogle Scholar
• Gerdle B, Forsgren MF, Bengtsson A, et al. Decreased muscle concentrations of ATP and PCR in the quadriceps muscle of fibromyalgia patients - A (31) P-MRS study. Eur J Pain (London, England) 2013; Epub ahead of print
   Google Scholar
• Cordero MD, Moreno-Fernandez AM, Carmona-Lopez MI, et al. Mitochondrial dysfunction in skin biopsies and blood mononuclear cells from two cases of fibromyalgia patients. Clin Biochem 2010;43(13-14):1174-6
   PubMedGoogle Scholar
• Park JH, Niermann KJ, Olsen N. Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia. Curr Rheumatol Rep 2000;2(2):131-40
   PubMedGoogle Scholar
• Pongratz DE, Spath M. Morphologic aspects of fibromyalgia. Z Rheumatol 1998;57(Suppl 2):47-51
   PubMedGoogle Scholar
• Sprott H, Salemi S, Gay RE, et al. Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres. Ann Rheum Dis 2004;63(3):245-51
   PubMedGoogle Scholar
• Rombaut L, Malfait F, De Paepe A, et al. Impairment and impact of pain in female patients with Ehlers-Danlos syndrome: a comparative study with fibromyalgia and rheumatoid arthritis. Arthritis Rheum 2011;63(7):1979-87
   PubMed Web of Science ®Google Scholar
• Grumati P, Coletto L, Sandri M, Bonaldo P. Autophagy induction rescues muscular dystrophy. Autophagy 2011;7(4):426-8
   PubMed Web of Science ®Google Scholar
• Grumati P, Coletto L, Schiavinato A, et al. Physical exercise stimulates autophagy in normal skeletal muscles but is detrimental for collagen VI-deficient muscles. Autophagy 2011;7(12):1415-23
   PubMed Web of Science ®Google Scholar
• Cordero MD, Diaz-Parrado E, Carrion AM, et al. Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia? Antioxid Redox Signal 2013;18(7):800-7
   PubMed Web of Science ®Google Scholar
• Cordero MD, Alcocer-Gomez E, Cano-Garcia FJ, et al. Clinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma. PLoS One 2011;6(10):e26915
   PubMedGoogle Scholar
• Meeus M, Nijs J. Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 2007;26(4):465-73
   PubMed Web of Science ®Google Scholar
• Arendt-Nielsen L, Graven-Nielsen T. Central sensitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Rep 2003;7(5):355-61
   PubMedGoogle Scholar
• Staud R, Robinson ME, Price DD. Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J Pain 2007;8(11):893-901
   PubMed Web of Science ®Google Scholar
• Staud R, Smitherman ML. Peripheral and central sensitization in fibromyalgia: pathogenetic role. Curr Pain Headache Rep 2002;6(4):259-66
   PubMedGoogle Scholar
• Staud R, Vierck CJ, Cannon RL, et al. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001;91(1-2):165-75
   PubMed Web of Science ®Google Scholar
• Baranauskas G, Nistri A. Sensitization of pain pathways in the spinal cord: cellular mechanisms. Prog Neurobiol 1998;54(3):349-65
   PubMedGoogle Scholar
• Tan EC, Janssen AJ, Roestenberg P, et al. Mitochondrial dysfunction in muscle tissue of complex regional pain syndrome type I patients. Eur J Pain (London, England) 2011;15(7):708-15
   PubMedGoogle Scholar
• Wood PB. A reconsideration of the relevance of systemic low-dose ketamine to the pathophysiology of fibromyalgia. J Pain 2006;7(9):611-14
   PubMedGoogle Scholar
• Sorensen J, Bengtsson A, Backman E, et al. Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol 1995;24(6):360-5
   PubMed Web of Science ®Google Scholar
• Graven-Nielsen T, Aspegren Kendall S, Henriksson KG, et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000;85(3):483-91
   PubMed Web of Science ®Google Scholar
• Kim HY, Chung JM, Chung K. Increased production of mitochondrial superoxide in the spinal cord induces pain behaviors in mice: the effect of mitochondrial electron transport complex inhibitors. Neurosci Lett 2008;447(1):87-91
   PubMedGoogle Scholar
• Wang ZQ, Porreca F, Cuzzocrea S, et al. A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther 2004;309(3):869-78
   PubMed Web of Science ®Google Scholar
• Goupille P, Jayson MI, Valat JP, Freemont AJ. The role of inflammation in disk herniation-associated radiculopathy. Semin Arthritis Rheum 1998;28(1):60-71
   PubMedGoogle Scholar
• Vikman KS, Hill RH, Backstrom E, et al. Interferon-gamma induces characteristics of central sensitization in spinal dorsal horn neurons in vitro. Pain 2003;106(3):241-51
   PubMedGoogle Scholar
• Kim HK, Park SK, Zhou JL, et al. Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain 2004;111(1-2):116-24
   PubMed Web of Science ®Google Scholar
• Lee I, Kim HK, Kim JH, et al. The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons. Pain 2007;133(1-3):9-17
   PubMedGoogle Scholar
• Schwartz ES, Kim HY, Wang J, et al. Persistent pain is dependent on spinal mitochondrial antioxidant levels. J Neurosci 2009;29(1):159-68
   PubMedGoogle Scholar
• Joseph EK, Levine JD. Mitochondrial electron transport in models of neuropathic and inflammatory pain. Pain 2006;121(1-2):105-14
   PubMedGoogle Scholar
• Schwartz ES, Lee I, Chung K, Chung JM. Oxidative stress in the spinal cord is an important contributor in capsaicin-induced mechanical secondary hyperalgesia in mice. Pain 2008;138(3):514-24
   PubMedGoogle Scholar
• Mattson MP, Liu D. Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. Neuromolecular Med 2002;2(2):215-31
   PubMedGoogle Scholar
• Desai KM, Chang T, Wang H, et al. Oxidative stress and aging: is methylglyoxal the hidden enemy? Can J Physiol Pharmacol 2010;88(3):273-84
   PubMed Web of Science ®Google Scholar
• Fischer LR, Igoudjil A, Magrane J, et al. SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse. Brain 2011;134(Pt 1):196-209
   PubMedGoogle Scholar
• Igoudjil A, Magrane J, Fischer LR, et al. In vivo pathogenic role of mutant SOD1 localized in the mitochondrial intermembrane space. J Neurosci 2011;31(44):15826-37
   PubMed Web of Science ®Google Scholar
• Weidinger A, Dungel P, Perlinger M, et al. Experimental data suggesting that inflammation mediated rat liver mitochondrial dysfunction results from secondary hypoxia rather than from direct effects of inflammatory mediators. Frontiers Physiol 2013;4:138
   PubMedGoogle Scholar
• Maes M, Twisk FN, Ringel K. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Psychother Psychosom 2012;81(5):286-95
   PubMed Web of Science ®Google Scholar
• Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev 2000;5(2):93-108
   PubMedGoogle Scholar
• Maes M, Mihaylova I, Kubera M, et al. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinol Lett 2009;30(4):470-6
   PubMed Web of Science ®Google Scholar
• Cordero MD, Moreno-Fernandez AM, deMiguel M, et al. Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia. Clin Biochem 2009;42(7-8):732-5
   PubMedGoogle Scholar
• Kim YS, Kim KM, Lee DJ, et al. Women with fibromyalgia have lower levels of calcium, magnesium, iron and manganese in hair mineral analysis. J Korean Med Sci 2011;26(10):1253-7
   PubMedGoogle Scholar
• Cordero MD, Cotan D, del-Pozo-Martin Y, et al. Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient. Nutrition 2012;28(11-12):1200-3
   PubMed Web of Science ®Google Scholar
• Boldyrev AA, Stvolinsky SL, Fedorova TN, Suslina ZA. Carnosine as a natural antioxidant and geroprotector: from molecular mechanisms to clinical trials. Rejuvenation Res 2010;13(2-3):156-8
   PubMedGoogle Scholar
• Derave W, Everaert I, Beeckman S, Baguet A. Muscle carnosine metabolism and beta-alanine supplementation in relation to exercise and training. Sports Med (Auckland, NZ) 2010;40(3):247-63
   PubMed Web of Science ®Google Scholar
• Xu Q, Si LY. Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action. Nutr Res 2012;32(9):648-58
   PubMed Web of Science ®Google Scholar
• Kessler HS, Sisson SB, Short KR. The potential for high-intensity interval training to reduce cardiometabolic disease risk. Sports Med (Auckland, NZ) 2012;42(6):489-509
   PubMed Web of Science ®Google Scholar
• Brown MD, Srinivasan M, Hogikyan RV, et al. Nitric oxide biomarkers increase during exercise-induced vasodilation in the forearm. Int J Sports Med 2000;21(2):83-9
   PubMedGoogle Scholar
• Green DJ, Maiorana A, O'Driscoll G, Taylor R. Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol 2004;561(Pt 1):1-25
   PubMed Web of Science ®Google Scholar
• Jammes Y, Steinberg JG, Mambrini O, et al. Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J Intern Med 2005;257(3):299-310
   PubMed Web of Science ®Google Scholar
• Lane RJ, Barrett MC, Taylor DJ, et al. Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle. Neuromuscul Disord 1998;8(3-4):204-9
   PubMedGoogle Scholar
• Shen W, Hintze TH, Wolin MS. Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 1995;92(12):3505-12
   PubMedGoogle Scholar
• Tatsumi T, Matoba S, Kawahara A, et al. Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes. J Am Coll Cardiol 2000;35(5):1338-46
   PubMedGoogle Scholar
• Qian ZM, Xiao DS, Ke Y, Liao QK. Increased nitric oxide is one of the causes of changes of iron metabolism in strenuously exercised rats. Am J Physiol Regul Integr Comp Physiol 2001;280(3):R739-43
   PubMedGoogle Scholar
• Fulle S, Pietrangelo T, Mancinelli R, et al. Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis. J Muscle Res Cell Motil 2007;28(6):355-62
   PubMedGoogle Scholar
• Radak Z, Pucsok J, Mecseki S, et al. Muscle soreness-induced reduction in force generation is accompanied by increased nitric oxide content and DNA damage in human skeletal muscle. Free Radic Boil Med 1999;26(7-8):1059-63
   PubMedGoogle Scholar
• Meeus M, Van Eupen I, Hondequin J, et al. Nitric oxide concentrations are normal and unrelated to activity level in chronic fatigue syndrome: a case-control study. In vivo (Athens, Greece) 2010;24(6):865-9
   PubMed Web of Science ®Google Scholar